Vanguard Personalized Indexing Management, LLC Sarepta Therapeutics, Inc. Transaction History
Vanguard Personalized Indexing Management, LLC
- $6.61 Billion
- Q1 2025
A detailed history of Vanguard Personalized Indexing Management, LLC transactions in Sarepta Therapeutics, Inc. stock. As of the latest transaction made, Vanguard Personalized Indexing Management, LLC holds 6,176 shares of SRPT stock, worth $236,849. This represents 0.01% of its overall portfolio holdings.
Number of Shares
6,176
Previous 7,708
19.88%
Holding current value
$236,849
Previous $937,000
57.95%
% of portfolio
0.01%
Previous 0.01%
Shares
14 transactions
Others Institutions Holding SRPT
# of Institutions
506Shares Held
88.9MCall Options Held
1.39MPut Options Held
1.13M-
Black Rock Inc. New York, NY10.3MShares$396 Million0.04% of portfolio
-
Capital International Investors Los Angeles, CA9.06MShares$347 Million0.12% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.03MShares$346 Million0.01% of portfolio
-
State Street Corp Boston, MA4.07MShares$156 Million0.01% of portfolio
-
Janus Henderson Group PLC London, X03.36MShares$129 Million0.12% of portfolio
About Sarepta Therapeutics, Inc.
- Ticker SRPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 87,567,904
- Market Cap $3.36B
- Description
- Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...